May 8 news, according to Onchain Lens monitoring, after being dormant for 9 months, a whale has re-staked 20,000 SOL (worth $3.02 million).
Currently, the whale holds 128,384 SOL (worth $19.6 million) in staking.
May 8 news, according to Onchain Lens monitoring, after being dormant for 9 months, a whale has re-staked 20,000 SOL (worth $3.02 million).
Currently, the whale holds 128,384 SOL (worth $19.6 million) in staking.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.
